A Premium Dermal Filler with CE Marking

[의학신문·일간보사=오인규 기자] Joonghun Pharmaceutical has officially launched their premium hyaluronic acid filler, Lorient, declaring a new era of dermal fillers. Lorient has successfully obtained the European Certification (CE mark) in late 2020, right after being approved by the MFDS in Korea, which proves its conformity to the global standards and outstanding quality as a premium filler.

Lorient, which has been developed over a period of 4 years, is expected to create a sensation in the global beauty market with its excellent safety and efficacy that will satisfy both practitioners and patients.

Lorient No.2, No.4, and No.6

Smooth and Natural Practice

One of Lorient’s prominent features is the smooth and consistent injection force, which enables writing letters with Lorient. Lorient’s low and consistent injection force allows precise procedures at the intended area effortlessly with the exact intended amount. The possibility of tissue damage could be reduced as well, due to the low pressure of the gel when entering the dermal tissue. After injection, Lorient forms the natural shape as intended by the practitioner while staying in the right place without flowing down, due to Lorient’s specially designed properties.

Letters written with Lorient

A Filler of Cleanliness

Impurities in fillers can cause side effects such as inflammatory reactions. Therefore, Lorient controls impurities beyond general standards, by in-house standards established with stricter specifications between European and Korean Pharmacopoeia standards. In addition, GMP standards for pharmaceutical injections are applied to Lorient, even though dermal fillers are classified as medical devices that are regulated with lower standards. From the use of raw materials to product release, most of manufacturing processes are controlled in cleanroom areas. As a result, Lorient has become an exceptional dermal filler with significantly low insoluble particles and endotoxin levels that are lower than the limit of detection.

Perfectly Designed Cross-Linking Technology

Lorient makes use of Joonghun’s proprietary cross-linking technology designed to increase the cross-linking rate. As such, Lorient succeeded in minimizing the input amount of cross-linking agent called BDDE, a cross-linking agent used for cross-linking of hyaluronic acid that can act as a hazardous substance when residual BDDE that have not made bonds with hyaluronic acid. Therefore, increasing the input amount of BDDE without raising cross-linking rate can easily lead to the increase of residual BDDE. Lorient’s cross-linking technology can be visually observed through electron microscopic images of Lorient gel’s large, uniform porous network structure, which contributes to natural results and safety when injected within the human body. Lorient’s original technology for optimizing of cross-linking rate is remarkable in aspects of safety and efficiency proven through solid data.

A Scanning Electron Microscope (SEM) image of Lorient gel

Where It Should Be

We conducted endless research to make Lorient similar to the human skin, for you to feel as if it was originally a part of your body. For your body not to recognize the filler as a foreign substance and minimize side effects caused by immune reactions, Lorient has components similar to the skin. Lorient was designed to have an osmotic pressure of 300 mOsm/kg, which is extremely close to the environment in human body.

Therefore, when injected, the sense of being a foreign body and pain would be minimized. Furthermore, through a comparative clinical study with a global-leading product that has been recognized worldwide for decades, Lorient was proven to have minimal side effects and excellent efficacy. In terms of product safety and efficacy Lorient is scientifically proven to be a world class filler.

Lorient is currently ongoing and planning several studies with renowned key opinion leaders in the aesthetics industry to prove the values of Lorient that differ significantly from other previously released fillers, with the aim of presentation at various conferences. Also, Lorient will continue active marketing and securing sales channels worldwide, with the core value of providing the most beautiful and unforgettable experience, for all who use Lorient including practitioners and patients.

[Meet the on-line version of Medical Newspaper special edition articles that are distributed physically at KIMES 2021]

저작권자 © 의학신문 무단전재 및 재배포 금지